Recent findings showed that elevated cholesterol levels promote the lipid raft localization of CD44 in a palmitoylation-dependent manner, disrupting CD44-Ezrin interactions, and ultimately decreasing the migration and metastasis of hepatocellular carcinoma (HCC) cells [125]. This evidence concerns the gene CD44 and hepatocellular carcinoma.